Company: DVAX
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001029142-25-000071
Chunk: 208

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-05-06
Form: 10-Q
Item: Part II, Item 3
Chunk 208
---
2S-1/AJanuary 16, 2004333-109965 4.3Indenture between Company and U.S. Bank National Association, as trustee, dated May 13, 20214.18-KMay 13, 2021 001-34207  4.4Form of Global Note, representing Dynavax Technologies Corporation’s 2.50% Convertible Senior Notes due 20264.28-KMay 13, 2021001-34207 4.5Rights Agreement, dated as of October 28, 2024, between Company and Computershare Trust Company, N.A., which includes the form of Amended and Restated Certificate of Designation as Exhibit A and the form of Right Certificate as Exhibit B4.18-KOctober 29, 2024001-342074.6Indenture, dated as of March 13, 2025, between Company and U.S. Bank Trust Company, National Association, as Trustee4.18-KMarch 13, 2025001-342074.7Form of 2.00% Convertible Senior Notes due 2030 (included as Exhibit A to Exhibit 4.6)4.28-KMarch 13, 2025001-34207

71

Table of Contents

10.1^Supply Agreement, dated February 10, 2025, between Company and West Pharmaceutical Services, Inc.10.3010-KFebruary 20, 2025001-3420710.2Form of Exchange and Subscription Agreement10.18-KMarch 6, 2025001-3420731.1Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002    X31.2Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002    X32.1*Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002    X32.2*Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002    X

EX—101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.EX—101.SCHInline XBRL Taxonomy Extension Schema DocumentEX—104Cover Page Interactive